Related Experiment Videos
Calcium/calmodulin kinase II activity of hippocampus in kainate-induced epilepsy
1Department of Pathology, Chonnam National University Medical School and Research Institute of Medical Sciences, Kwangju, Korea. mclee@chonnam.ac.kr
Abstract:
This study investigated calcium/calmodulin kinase II (CaMKII) activity related to long-standing neuronal injury of the hippocampus in kainate (KA)-induced experimental temporal lobe epilepsy. Epileptic seizure was induced by injection of KA (1 microg/microL) dissolved in phosphate buffer (0.1 M, pH 7.4) into the left amygdala. Clinical seizures, histopathologic changes and CaMKII activity of the hippocampus were evaluated. Characteristic early limbic and late seizures were developed. Hippocampal CaMKII activity increased significantly 4 and 8 weeks after intra-amygdaloid injection of KA, when late seizures developed. The histopathologic changes of the hippocampus included swelling of neuronal cytoplasm with nuclear pyknosis and loss of neurons in CA3 during this period. The increased activity of CaMKII may correlate with appearance of distant damage in the hippocampus. The above results indicate that intra-amygdaloid injection of KA produces excitatory signals for ipsilateral CA3 neurons in the hippocampus and that subsequently increased levels of CaMKII in postsynaptic neurons induce neuronal injury via phosphorylation of N-methyl-D-aspartate type glutamate receptor.
Insights
This study shows that increased calcium/calmodulin kinase II (CaMKII) activity in the hippocampus correlates with neuronal injury in experimental temporal lobe epilepsy. This suggests CaMKII plays a role in epilepsy-related brain damage.
Area of Science:
- Neuroscience
- Epilepsy Research
- Molecular Biology
Background:
- Temporal lobe epilepsy is a neurological disorder characterized by recurrent seizures.
- Neuronal injury in the hippocampus is a common feature of chronic epilepsy.
- Calcium/calmodulin kinase II (CaMKII) is a crucial enzyme involved in synaptic plasticity and neuronal function.
Purpose of the Study:
- To investigate the role of CaMKII activity in hippocampal neuronal injury in a kainate-induced epilepsy model.
- To explore the correlation between CaMKII activation and seizure development.
- To elucidate the molecular mechanisms underlying epilepsy-related neurodegeneration.
Main Methods:
- Induction of experimental temporal lobe epilepsy using intra-amygdaloid kainate injection in rats.
- Evaluation of clinical seizure activity, including early limbic and late seizures.
- Assessment of hippocampal histopathology and CaMKII activity at 4 and 8 weeks post-injection.
Main Results:
- Kainate injection successfully induced experimental temporal lobe epilepsy with characteristic seizures.
- Significant increase in hippocampal CaMKII activity was observed during the development of late seizures (4 and 8 weeks post-injection).
- Histopathological examination revealed neuronal swelling, nuclear pyknosis, and neuron loss in the CA3 region of the hippocampus.
Conclusions:
- Increased hippocampal CaMKII activity is associated with long-standing neuronal injury in kainate-induced experimental temporal lobe epilepsy.
- CaMKII may contribute to epilepsy-related hippocampal damage through the phosphorylation of N-methyl-D-aspartate type glutamate receptors.
- These findings highlight CaMKII as a potential therapeutic target for mitigating neuronal injury in temporal lobe epilepsy.